14-day Premium Trial Subscription Try For FreeGet Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CLDX
Powered by GPT-4
Stock Analysis
Risk Assessment
Trading Strategy

Celldex Therapeutics stock price ended on $29.19 on Monday after gaining 1.81%
(Updated on Nov 27, 2023)

Buy or Hold candidate since Nov 21, 2023 Gain 4.21% PDF
The Celldex Therapeutics stock price gained 1.81% on the last trading day (Monday, 27th Nov 2023), rising from $28.67 to $29.19. During the last trading day the stock fluctuated 3.99% from a day low at $28.16 to a day high of $29.28. The price has risen in 7 of the last 10 days and is up by 8.35% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 380 thousand more shares were traded than the day before. In total, 642 thousand shares were bought and sold for approximately $18.75 million.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

The stockhas broken the very wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is $29.09, a level that may pose a second chance to hit a runner. According to fan-theory $35.94 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

CLDX Signals & Forecast

The Celldex Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $28.25 and $26.22. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, November 06, 2023, and so far it has fallen -0.545%. Further fall is indicated until a new bottom pivot has been found.

Get your hands on a piece of history – invest in multi-million dollar paintings from $10k with Masterworks.

Support, Risk & Stop-loss for Celldex Therapeutics stock

Celldex Therapeutics finds support from accumulated volume at $27.90 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.12 between high and low, or 3.99%. For the last week, the stock has had daily average volatility of 5.64%.

Our recommended stop-loss: $28.00 (-4.09%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 14 days ago.)

Trading Expectations (CLDX) For The Upcoming Trading Day Of Tuesday 28th

For the upcoming trading day on Tuesday, 28th we expect Celldex Therapeutics to open at $28.88, and during the day (based on 14 day Average True Range), to move between $27.46 and $30.92, which gives a possible trading interval of +/-$1.73 (+/-5.92%) up or down from last closing price. If Celldex Therapeutics takes out the full calculated possible swing range there will be an estimated 11.84% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $29.35 (0.55%) than the support at $27.90 (4.42%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Celldex Therapeutics stock A Buy?

Celldex Therapeutics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.634 Open Broker Account

Hold/Accumulate Unchanged

Predicted Opening Price for Celldex Therapeutics of Tuesday, November 28, 2023

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Fair opening price November 28, 2023 Current price
$28.88 $29.19 (Overvalued)

Remember To Visit Our YouTube Channel

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 30.00 2.77 %
R2 29.57 1.30 %
R1 29.30 0.393 %
Current price: 29.19
Support S1 28.45 -2.55 %
S2 28.18 -3.45 %
S3 27.75 -4.92 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 29.35 0.548 %
Current price 29.19
Support S1 27.90 -4.42%
S2 26.94 -7.71%
S3 26.50 -9.22%
What is the symbol for Celldex Therapeutics Stock and on which exchange is it traded?
The symbol for Celldex Therapeutics is CLDX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Celldex Therapeutics Stock?
Celldex Therapeutics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Celldex Therapeutics Stock?
Celldex Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Celldex Therapeutics Stock.

What's the current price of Celldex Therapeutics Stock?
As of the end of day on the 2023-11-27, the price of an Celldex Therapeutics (CLDX) share was $29.19.

What is the 52-week high and low for Celldex Therapeutics Stock?
The 52-week high for Celldex Therapeutics Stock is $48.40 and the 52-week low is $22.11.

What is the market capitalization of Celldex Therapeutics Stock?
As of the 2023-11-27, the market capitalization of Celldex Therapeutics is 1.596B.

When is the next earnings date for Celldex Therapeutics?
The upcoming earnings date for Celldex Therapeutics is 2024-02-27 00:00:00.

Click to get the best stock tips daily for free!